All the data, all the trials: we take a look at the AllTrials initiative and the news that GSK are jumping on board. We also explore doping in Australian sport and discuss a new women's cancer initiative, a pollution treaty in Asia, condom delivery in Dubai, and how better school meals could stop kids getting so darned fat.

Gold, lead, and Goodluck: Nigeria's President releases US $4 million to clean up lead-contaminated villages in the wake of the country's gold rush. Also in the podcast, NFL stars pledge $100 million to health research...

The Beijing Cough: pollution in Beijing is getting out of hand, so what measures are the government taking to control the situation? Also in the podcast, poliovirus detected in Cairo's sewers, a day of zero tolerance to female genital mutilation...

Combating suicide: we look at why more active-duty troops in the USA died by suicide than in combat in Afghanistan in 2012. We also discuss China and the UK's new partnership to improve global health, IVF legislation in Costa Rica...

Mercury rising: In this week's podcast we look at a new global effort to control mercury emissions, why Spanish doctors are resigning en masse over privatisation, US stem cell laws, China's drug pricing, and more.

Measles surge in Pakistan: the number of measles deaths in Pakistan increased fivefold in 2012. We ask why. We also talk about HIV in China, a TB milestone, and one of the more bizarre stories from over the festive break-tune in to find out more.

The end of the human race: we discuss extinction-level risks with Lord Rees, Astronomer Royal and one of the founders of Cambridge University's Centre for the Study of Existential Risk.

Big Pharma ranking: we're joined by David Sampson, one of the authors of the 2012 Access to Medicines Index, which ranks the 20 biggest drug companies according to their efforts to improve access to drugs in low-income countries.

The Global Fund appoints a new leader: we speak with Ann Danaiya Usher, an editor at Development Today, about the appointment of Mark Dybul as the Executive Director of the Global Fund.

Bionic limbs, memory-enhancing drugs, or even hair transplantation-how will human enhancement change the people you work with? Tune in to find out.